

Mebita Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.17 M
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.26 Cr
- Revenue Growth 437.44%
- Profit Growth 447.79%
- Ebitda 497.61%
- Net Worth 402.07%
- Total Assets 150.61%
About Mebita Pharmaceutical
Mebita Pharmaceutical Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 August 2019 (Five years and eight months 7 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.17 M.
The company currently has active open charges totaling ₹1.26 Cr.
Rupesh Kumar, Nikhil Ranjan, Narendra Thakur, and Two other members serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24290DL2019PTC354287
- Company No.
354287
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Aug 2019
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Mebita Pharmaceutical?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Narendra Thakur ![]() | Managing Director | 27-Aug-2019 | Current |
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rupesh Kumar ![]() | Director | 27-Aug-2019 | Current |
Nikhil Ranjan ![]() | Director | 27-Aug-2019 | Current |
Abhimanyu Kumar ![]() | Director | 28-Feb-2020 | Current |
Vanibhushan ![]() | Director | 04-May-2022 | Current |
Financial Performance of Mebita Pharmaceutical.
Mebita Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 437.44% increase. The company also saw a substantial improvement in profitability, with a 447.79% increase in profit. The company's net worth Soared by an impressive increase of 402.07%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Mebita Pharmaceutical?
In 2022, Mebita Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹12.58 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 1.02 Cr
- Others : 0.24 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
31 May 2023 | Hdfc Bank Limited | ₹0.68 M | Open |
29 Jul 2022 | Hdfc Bank Limited | ₹9.50 M | Open |
21 Oct 2021 | Others | ₹2.40 M | Open |
How Many Employees Work at Mebita Pharmaceutical?
Mebita Pharmaceutical has a workforce of 48 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Mebita Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mebita Pharmaceutical's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Mebita Pharmaceutical
Recent activity within the organization
- Charges
A charge with Hdfc Bank Limited of Rs. 9.50 M registered on 29 Jul 2022 with Charge ID 100627973 was modified on 13 Feb 2024.
- Annual General Meeting
Mebita Pharmaceutical Private Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.
- Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.68 M with Charge ID 100821330 was registered on 31 May 2023.
- Balance Sheet
Mebita Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
- Charges
A charge with Hdfc Bank Limited amounted to Rs. 9.50 M with Charge ID 100627973 was registered on 29 Jul 2022.
- Director Appointment
Vanibhushan was appointed as a Director was appointed as a Director on 04 May 2022 & has been associated with this company since 3 years .
Frequently asked questions
What is the Incorporation or founding date of Mebita Pharmaceutical Private Limited?
Mebita Pharmaceutical Private Limited was incorporated on 27 Aug 2019.
What is authorized share capital and paid-up capital of Mebita Pharmaceutical Private Limited?
The authorized share capital of Mebita Pharmaceutical Private Limited is ₹ 2.50 M and paid-up capital is ₹ 1.17 M.
Who are the current board members & directors of Mebita Pharmaceutical Private Limited?
Currently 5 directors are associated with Mebita Pharmaceutical Private Limited.
- Rupesh Kumar
- Nikhil Ranjan
- Narendra Nath Thakur
- Abhimanyu Kumar
- Vanibhushan
What is the registered address of Mebita Pharmaceutical Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Mebita Pharmaceutical Private Limited is B-52 Ground Floor West Guru Angad Nagar, Laxmi Nagar India, East Delhi, 110092.
What is the corporate identification number (CIN) and company number of Mebita Pharmaceutical Private Limited?
The corporate identification number (CIN) of Mebita Pharmaceutical Private Limited is U24290DL2019PTC354287 and the company number is 354287 as per Ministry of Corporate Affairs (MCA).
What is the official website of Mebita Pharmaceutical Private Limited?
The Official website of Mebita Pharmaceutical Private Limited is https://www.mebitapharmaceutical.com
What has been the recent revenue trend for Mebita Pharmaceutical Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Mebita Pharmaceutical Private Limited has risen by 437.44%.
How many employees does Mebita Pharmaceutical Private Limited currently have?
As Per 2022 financial reports, 48 employees are currently employed by Mebita Pharmaceutical Private Limited.
What change has been observed in the net worth of Mebita Pharmaceutical Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Mebita Pharmaceutical Private Limited has experienced an upsurge of 402.07%.
What are the total open charges for Mebita Pharmaceutical Private Limited?
As per the financial statements for fiscal Year 2022, The total open charges for Mebita Pharmaceutical Private Limited amount to ₹ 1.26 Cr.
When was the last Balance Sheet of Mebita Pharmaceutical Private Limited filed with the ROC?
The most recent Balance Sheet for Mebita Pharmaceutical Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records